13F filer · CIK 1306923
Palo Alto Investors LP
PALO ALTO, CA · filing since Q2 2013 · last filing Aug 19, 2026
Reported value
$723.7M
+$69.9M vs prior
Positions
52
New / sold out
3 / 2
Added / reduced
5 / 15
Turnover
4.8%
buys $33.0M · sells $38.3M
Top-10 weight
61.3%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | FIRST TRACKS BIOTHERAPEUTICS | +603,489 | – | +$12.1M |
| Added | COMPASS THERAPEUTICS INC | +4,317,309 | +285.1% | +$9.5M |
| Added | CELLDEX THERAPEUTICS INC | +103,448 | +34.9% | +$3.8M |
| Added | MIRUM PHARMACEUTICALS INC | +23,633 | +7.3% | +$2.8M |
| New | SAGIMET BIOSCIENCES INC-A | +250,000 | – | +$1.9M |
| New | NEWAMSTERDAM PHARMA CO NV | +44,359 | – | +$1.5M |
| Added | DISC MEDICINE INC | +14,927 | +3.7% | +$1.1M |
| Added | VERASTEM INC | +63,592 | +25.8% | +$242.9K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | AMICUS THERAPEUTICS INC | -1,113,045 | -100.0% | $-16.1M |
| Sold out | DENALI THERAPEUTICS INC | -234,582 | -100.0% | $-4.5M |
| Reduced | IOVANCE BIOTHERAPEUTICS INC | -1,053,354 | -16.6% | $-4.4M |
| Reduced | TRAVERE THERAPEUTICS INC | -62,928 | -27.3% | $-3.6M |
| Reduced | ORUKA THERAPEUTICS INC - Restricted | -26,439 | -44.1% | $-2.5M |
| Reduced | ANAPTYSBIO INC | -34,672 | -5.4% | $-2.3M |
| Reduced | ALIGN TECHNOLOGY INC | -10,131 | -24.4% | $-1.7M |
| Reduced | NUVATION BIO INC | -182,237 | -35.8% | $-1.0M |
| Reduced | PROTHENA CORP PLC | -65,413 | -5.4% | $-640.4K |
| Reduced | PYXIS ONCOLOGY INC | -146,233 | -14.5% | $-440.2K |
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PTC THERAPEUTICS INCCOM | 918,846 | $75.0M | 10.36% |
| 2 | ACADIA PHARMACEUTICALS INCCOM | 2,864,096 | $72.5M | 10.01% |
| 3 | INSMED INCCOM PAR $.01 | 413,980 | $44.1M | 6.10% |
| 4 | MIRUM PHARMACEUTICALS INCCOM | 348,808 | $40.8M | 5.64% |
| 5 | ANAPTYSBIO INCCOM | 603,489 | $40.7M | 5.63% |
| 6 | BIOMARIN PHARMACEUTICAL INCCOM | 682,777 | $39.1M | 5.40% |
| 7 | DYNE THERAPEUTICS INCCOM | 1,647,521 | $36.6M | 5.06% |
| 8 | UNITED THERAPEUTICS CORPCOM | 62,587 | $33.9M | 4.69% |
| 9 | DISC MEDICINE INCCOM | 416,646 | $30.5M | 4.21% |
| 10 | BIOGEN INCCOM | 140,279 | $30.3M | 4.19% |
42 more rows. Subscribe for $29/month to see every row, download the data and use the API.